HyperScience Europe Limited 12233331 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is the provision of business support services. Digita Accounts Production Advanced 6.30.9574.0 true true 12233331 2024-03-01 2025-02-28 12233331 2025-02-28 12233331 bus:OrdinaryShareClass1 2025-02-28 12233331 bus:Consolidated 2025-02-28 12233331 core:CurrentFinancialInstruments 2025-02-28 12233331 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 12233331 core:FurnitureFittingsToolsEquipment 2025-02-28 12233331 bus:SmallEntities 2024-03-01 2025-02-28 12233331 bus:Audited 2024-03-01 2025-02-28 12233331 bus:FilletedAccounts 2024-03-01 2025-02-28 12233331 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12233331 bus:RegisteredOffice 2024-03-01 2025-02-28 12233331 bus:Director1 2024-03-01 2025-02-28 12233331 bus:Director4 2024-03-01 2025-02-28 12233331 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 12233331 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12233331 core:FurnitureFittings 2024-03-01 2025-02-28 12233331 core:FurnitureFittingsToolsEquipment 2024-03-01 2025-02-28 12233331 countries:EnglandWales 2024-03-01 2025-02-28 12233331 core:FurnitureFittingsToolsEquipment 2024-02-29 12233331 2023-03-01 2024-02-29 12233331 2024-02-29 12233331 bus:OrdinaryShareClass1 2024-02-29 12233331 core:CurrentFinancialInstruments 2024-02-29 12233331 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12233331



HyperScience Europe Limited

Annual Report and Financial Statements

for the Year Ended 28 February 2025

 

HyperScience Europe Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 7

 

HyperScience Europe Limited

Company Information

Directors

S Vineyard

J Joiner

Registered office

3rd Floor
1 Ashley Road
Altrincham
Cheshire
WA14 2DT

Auditors

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

HyperScience Europe Limited

(Registration number: 12233331)
Balance Sheet as at 28 February 2025

Note

2025
£

2024
£

Current assets

 

Debtors

5

389,855

339,170

Cash at bank and in hand

 

1,855,766

2,019,059

 

2,245,621

2,358,229

Creditors: Amounts falling due within one year

6

(784,419)

(1,164,700)

Net assets

 

1,461,202

1,193,529

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

1,461,102

1,193,429

Shareholders' funds

 

1,461,202

1,193,529

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 July 2025 and signed on its behalf by:
 


S Vineyard
Director

 

HyperScience Europe Limited

Notes to the Financial Statements for the Year Ended 28 February 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
3rd Floor
1 Ashley Road
Altrincham
Cheshire
WA14 2DT

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

HyperScience Europe Limited

Notes to the Financial Statements for the Year Ended 28 February 2025

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

25% on cost

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

HyperScience Europe Limited

Notes to the Financial Statements for the Year Ended 28 February 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 24 (2024 - 21).

 

HyperScience Europe Limited

Notes to the Financial Statements for the Year Ended 28 February 2025

 

4

Tangible assets

Furniture, fittings and equipment
 £

Cost

At 1 March 2024

114,625

Disposals

(114,625)

At 28 February 2025

-

Depreciation

At 1 March 2024

114,625

Eliminated on disposal

(114,625)

At 28 February 2025

-

Carrying amount

At 29 February 2024 and 28 February 2025

-

 

5

Debtors

2025
£

2024
£

Trade debtors

327

260

Receivables from related parties

-

9,452

Prepayments

271,036

246,437

Other debtors

118,492

83,021

389,855

339,170

 

6

Creditors

2025
£

2024
£

Due within one year

Trade creditors

94,871

22,702

Amounts due to related parties

587,818

1,039,537

Corporation tax liability

89,726

92,704

Accrued expenses

9,874

9,757

Other creditors

2,130

-

784,419

1,164,700

 

HyperScience Europe Limited

Notes to the Financial Statements for the Year Ended 28 February 2025

 

7

Share capital

Allotted, called up and fully paid shares

 

2025

2024

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

         
 

8

Related party transactions

During the period, HyperScience Europe Limited made sales to its immediate parent company Hyper Labs Inc of £4,543,470 (2024: £4,326,756). As at 28 February 2025, the balance owed to Hyper Labs Inc. was £587,818 (2024: £1,039,537).

At the year end, HyperScience Europe Limited was owed nil from other group companies (2024: £9,452)

 

9

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 28 July 2025 was Ryan Hancock, who signed for and on behalf of Hazlewoods LLP.